DK1287133T3 - Regulering af human dopamin-lignende G-protein-koblet receptor - Google Patents
Regulering af human dopamin-lignende G-protein-koblet receptorInfo
- Publication number
- DK1287133T3 DK1287133T3 DK01945139T DK01945139T DK1287133T3 DK 1287133 T3 DK1287133 T3 DK 1287133T3 DK 01945139 T DK01945139 T DK 01945139T DK 01945139 T DK01945139 T DK 01945139T DK 1287133 T3 DK1287133 T3 DK 1287133T3
- Authority
- DK
- Denmark
- Prior art keywords
- protein
- coupled receptor
- regulation
- human dopamine
- obesity
- Prior art date
Links
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 title abstract 4
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 208000008589 Obesity Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 235000020824 obesity Nutrition 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 206010003805 Autism Diseases 0.000 abstract 1
- 208000020706 Autistic disease Diseases 0.000 abstract 1
- 208000023105 Huntington disease Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 208000027089 Parkinsonian disease Diseases 0.000 abstract 1
- 206010034010 Parkinsonism Diseases 0.000 abstract 1
- 206010047700 Vomiting Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000004064 dysfunction Effects 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 230000008673 vomiting Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20519500P | 2000-05-18 | 2000-05-18 | |
| PCT/EP2001/005559 WO2001087929A2 (en) | 2000-05-18 | 2001-05-16 | Regulation of human dopamine-like g protein-coupled receptor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1287133T3 true DK1287133T3 (da) | 2007-03-26 |
Family
ID=22761200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01945139T DK1287133T3 (da) | 2000-05-18 | 2001-05-16 | Regulering af human dopamin-lignende G-protein-koblet receptor |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1287133B1 (da) |
| AT (1) | ATE348162T1 (da) |
| AU (1) | AU6744501A (da) |
| CY (1) | CY1105966T1 (da) |
| DE (1) | DE60125169T2 (da) |
| DK (1) | DK1287133T3 (da) |
| ES (1) | ES2278755T3 (da) |
| PT (1) | PT1287133E (da) |
| WO (1) | WO2001087929A2 (da) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030017528A1 (en) | 1998-11-20 | 2003-01-23 | Ruoping Chen | Human orphan G protein-coupled receptors |
| USRE42190E1 (en) | 1998-11-20 | 2011-03-01 | Arena Pharmaceuticals, Inc. | Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors |
| US7816492B2 (en) | 1998-11-20 | 2010-10-19 | Arena Pharmaceuticals, Inc. | Human G protein-coupled receptors |
| EP1770159A1 (en) * | 2000-12-01 | 2007-04-04 | Astellas Pharma Inc. | Process for manufacturing a pharmaceutical composition for treating diabetes |
| HRP20050696B1 (en) | 2003-01-14 | 2008-10-31 | Arena Pharmaceuticals Inc. | 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| US7083933B1 (en) | 2003-05-09 | 2006-08-01 | Prosidion Limited | Methods for identification of modulators of OSGPR116 activity |
| AR045047A1 (es) | 2003-07-11 | 2005-10-12 | Arena Pharm Inc | Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos |
| US7132426B2 (en) | 2003-07-14 | 2006-11-07 | Arena Pharmaceuticals, Inc. | Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| DOP2006000010A (es) | 2005-01-10 | 2006-07-31 | Arena Pharm Inc | Procedimiento para preparar eteres aromáticos |
| MY148521A (en) | 2005-01-10 | 2013-04-30 | Arena Pharm Inc | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| DOP2006000008A (es) | 2005-01-10 | 2006-08-31 | Arena Pharm Inc | Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1 |
| DE602007010420D1 (de) | 2006-04-11 | 2010-12-23 | Arena Pharm Inc | Verfahren zur verwendung des gpr119-rezeptors zur identifizierung von verbindungen zur erhöhung der knochenmasse bei einer person |
| PE20071221A1 (es) | 2006-04-11 | 2007-12-14 | Arena Pharm Inc | Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas |
| BRPI0817211A2 (pt) | 2007-09-20 | 2017-05-16 | Irm Llc | composto composições como moduladores da atividade de gpr119 |
| EP2146210A1 (en) | 2008-04-07 | 2010-01-20 | Arena Pharmaceuticals, Inc. | Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY |
| MX2013003184A (es) | 2010-09-22 | 2013-06-07 | Arena Pharm Inc | Moduladores del receptor gpr119 y el tratamiento de transtornos relacionados con el mismo. |
| US11007175B2 (en) | 2015-01-06 | 2021-05-18 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the S1P1 receptor |
| BR112017027656B1 (pt) | 2015-06-22 | 2023-12-05 | Arena Pharmaceuticals, Inc. | Hábito cristalino de placa livre de sal de l-arginina de ácido (r)-2-(7-(4- ciclopentil-3-(trifluorometil)benzilóxi)- 1,2,3,4-tetra-hidrociclo-penta[b]indol-3- il)acético, composição farmacêutica que o compreende, seus usos e método de preparação do mesmo |
| BR112020024762A2 (pt) | 2018-06-06 | 2021-03-23 | Arena Pharmaceuticals, Inc. | métodos de tratamento de condições relacionadas ao receptor s1p1 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010080882A (ko) * | 1998-10-13 | 2001-08-25 | 리처드 피. 버군 쥬니어 | 구성적으로 활성화된 비내생성 인간 ｇ 단백질 결합형수용체 |
| PT1133559E (pt) * | 1998-11-20 | 2005-10-31 | Arena Pharm Inc | Receptor acoplato a proteina g orfao humano, rup3 |
| US6221660B1 (en) * | 1999-02-22 | 2001-04-24 | Synaptic Pharmaceutical Corporation | DNA encoding SNORF25 receptor |
| GB9923177D0 (en) * | 1999-09-30 | 1999-12-01 | Pfizer Ltd | Novel polypeptide |
| WO2001032864A2 (en) * | 1999-11-03 | 2001-05-10 | Merck Patent Gmbh | Gpcr-kd5 polypeptides and dna sequences thereof |
| WO2001036473A2 (en) * | 1999-11-16 | 2001-05-25 | Pharmacia & Upjohn Company | Human g protein-coupled receptors |
| JP2004500808A (ja) * | 1999-12-10 | 2004-01-15 | インサイト・ゲノミックス・インコーポレイテッド | Ｇタンパク質結合受容体 |
-
2001
- 2001-05-16 AT AT01945139T patent/ATE348162T1/de not_active IP Right Cessation
- 2001-05-16 EP EP01945139A patent/EP1287133B1/en not_active Expired - Lifetime
- 2001-05-16 DE DE60125169T patent/DE60125169T2/de not_active Expired - Fee Related
- 2001-05-16 ES ES01945139T patent/ES2278755T3/es not_active Expired - Lifetime
- 2001-05-16 WO PCT/EP2001/005559 patent/WO2001087929A2/en not_active Ceased
- 2001-05-16 DK DK01945139T patent/DK1287133T3/da active
- 2001-05-16 PT PT01945139T patent/PT1287133E/pt unknown
- 2001-05-16 AU AU67445/01A patent/AU6744501A/en not_active Abandoned
-
2007
- 2007-01-29 CY CY20071100122T patent/CY1105966T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1287133B1 (en) | 2006-12-13 |
| ES2278755T3 (es) | 2007-08-16 |
| ATE348162T1 (de) | 2007-01-15 |
| DE60125169T2 (de) | 2007-11-22 |
| EP1287133A2 (en) | 2003-03-05 |
| WO2001087929A3 (en) | 2002-05-30 |
| DE60125169D1 (de) | 2007-01-25 |
| PT1287133E (pt) | 2007-03-30 |
| CY1105966T1 (el) | 2011-04-06 |
| AU6744501A (en) | 2001-11-26 |
| WO2001087929A2 (en) | 2001-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1287133T3 (da) | Regulering af human dopamin-lignende G-protein-koblet receptor | |
| WO2002085285A3 (en) | Methods and reagents for regulating bone and cartilage formation | |
| NO20092822L (no) | Kjernereseptorbindende midler | |
| MXPA05009524A (es) | Derivados de imidazol-4-il-etinil-piridina. | |
| WO2007038636A3 (en) | Estriol therapy for autoimmune and neurodegenerataive diseases and disorders | |
| WO2001092297A3 (en) | Regulation of human lgr4-like g protein-coupled receptor | |
| WO2002038760A3 (en) | Regulation of human extracellular calcium-sensing g protein-coupled receptor | |
| WO2005014797A3 (en) | P16 mediated regulation of nmda receptors | |
| WO2001088127A3 (en) | Regulation of human follicle stimulating hormone-like g protein-coupled receptor | |
| ATE394487T1 (de) | Menschlicher g-protein gekoppelter rezeptor | |
| WO2002028898A3 (en) | Regulation of human secretin receptor-like gpcr | |
| WO2001092296A3 (en) | Regulation of human isotocin-like g protein-coupled receptor | |
| WO2002000701A3 (en) | Regulation of human gonadotropin releasing hormone receptor-like g protein-coupled receptor | |
| ATE315089T1 (de) | Regulierung des menschlichen p2y1-ähnlichen g- protein gekoppelten rezeptors | |
| WO2002029052A3 (en) | Regulation of human secretin receptor-like gpcr | |
| IL165946A0 (en) | Potassium channel sub-units their preparation and use | |
| WO2002029051A3 (en) | Human secretin receptor-like gpcr | |
| WO2001088126A8 (en) | REGULATION OF HUMAN α1Α ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR | |
| WO2002059302A3 (en) | Regulation of human serotonin-like g protein-coupled receptor | |
| WO2001068702A3 (en) | Regulation of human g protein-coupled receptor | |
| WO2001068701A3 (en) | Regulation of human seven transmembrane - like g protein - coupled receptor (7tm-gpcr) | |
| WO2005040790A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 75 (gpr75) | |
| WO2004048978A3 (en) | Diagnostics and therapeutics for diseases associated with bile acid g-protein-coupled receptor 37 (bg37) | |
| WO2005108998A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor beta-3 adreno (adrb3) | |
| WO2004099248A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor agtr2 (agtr2) |